Skip to main content

Emerald Advisers, LLC

SEC CIK
0001015083
Latest filing
Aug 5, 2026

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings

Shares (Q2 2026)
685,683
Value
$10.2M
% of portfolio
0.2%
Quarters held
2
Since Q1 2026
Holdings of CRVS by Emerald Advisers, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026685,683$10.2M0.2%−533−0.1%ReducedHolders
Q1 2026686,216$10.0M0.3%+686,216NewHolders